Find policies, billing codes, payers, states, and providers
CPT 84703: hCG Detection in Blood (Laboratory Assay)
CPT code 84703 denotes a laboratory assay to detect human chorionic gonadotropin (hCG) in blood. This code is used nationally for clinical testing that informs pregnancy diagnosis, monitoring of gestational trophoblastic disease, and evaluation of hCG-secreting tumors. Accurate coding of hCG testing supports clinical workflows, claims processing, and public health reporting where relevant.
Key payers covered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of standard clinical contexts for hCG testing, common sites of service for specimen collection and analysis, and a concise summary of billing considerations tied to CPT code 84703.
This publication provides national-level benchmarks and policy-relevant context for laboratory administrators, billing staff, and health plan analysts. It summarizes typical service settings, explains why hCG assays matter clinically and administratively, and highlights areas where coding clarity affects reimbursement and care coordination. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 84703 policy alerts
Get alerted when payer policies referencing 84703 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 84703 represents a laboratory test that detects the presence of human chorionic gonadotropin (hCG) hormone, typically performed on patient blood. The analysis task performed by the lab analyst identifies hCG to support clinical decisions such as pregnancy detection, monitoring of trophoblastic disease, or evaluation of certain tumors.
Service type: Laboratory testing — qualitative or quantitative hCG assay
Typical site of service: Clinical laboratory or hospital laboratory; specimen collected in an outpatient clinic, emergency department, or inpatient setting